Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases.

[1]  C. Cooper,et al.  Clinical Guidelines on Paget's Disease of Bone , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  B. Zemel,et al.  Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Periprosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[3]  B. Mitlak,et al.  Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial , 2019, Current medical research and opinion.

[4]  Jennifer B. McCormick,et al.  Patients’ views on variants of uncertain significance across indications , 2019, Journal of Community Genetics.

[5]  J. Weissman,et al.  Fracture Risk After Roux-en-Y Gastric Bypass vs Adjustable Gastric Banding Among Medicare Beneficiaries. , 2019, JAMA surgery.

[6]  Cecelia P. Tamburro,et al.  Genomic medicine for undiagnosed diseases , 2019, The Lancet.

[7]  M. Zillikens,et al.  The Official Positions of the International Society for Clinical Densitometry: Detection of Atypical Femur Fractures. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[8]  S. Schneeweiss,et al.  Fracture Risk After Initiation of Use of Canagliflozin , 2019, Annals of Internal Medicine.

[9]  J. Manson,et al.  Menopausal Hormone Therapy. , 2019, JAMA.

[10]  J. Bilezikian,et al.  Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group , 2019, Osteoporosis International.

[11]  C. Cooper,et al.  Fracture risk following intermission of osteoporosis therapy , 2019, Osteoporosis International.

[12]  J. Reginster,et al.  Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  R. Eastell,et al.  Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. , 2019, The Journal of clinical endocrinology and metabolism.

[14]  E. Lewiecki,et al.  Project ECHO: Telehealth to Expand Capacity to Deliver Best Practice Medical Care. , 2019, Rheumatic diseases clinics of North America.

[15]  O. Semler,et al.  Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases , 2019, Pediatric Drugs.

[16]  G. Baek,et al.  Lower Trabecular Bone Score is Associated With the Use of Proton Pump Inhibitors. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[17]  L. Fayad,et al.  Heterotopic Ossification: A Comprehensive Review , 2019, JBMR plus.

[18]  J. Cauley,et al.  Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  A. Grauer,et al.  One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  I. Reid,et al.  Fracture Prevention with Zoledronate in Older Women with Osteopenia , 2018, The New England journal of medicine.

[21]  H. van Marwijk,et al.  Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta‐analysis , 2018, International journal of geriatric psychiatry.

[22]  M. Bouxsein,et al.  Longitudinal 5-Year Evaluation of Bone Density and Microarchitecture After Roux-en-Y Gastric Bypass Surgery. , 2018, The Journal of clinical endocrinology and metabolism.

[23]  J. Bilezikian.  Primary Hyperparathyroidism , 2018, The Journal of clinical endocrinology and metabolism.

[24]  P. Geusens,et al.  Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis , 2018, The Journal of clinical endocrinology and metabolism.

[25]  Xuezhi Jiang.  Hormone therapy for the treatment of postmenopausal osteoporosis: will it soon become a lost art in medicine? , 2018, Menopause.

[26]  J. S. San Martin,et al.  A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Anoop Kumar,et al.  Risks Associated with SGLT2 Inhibitors: An Overview. , 2018, Current drug safety.

[28]  E. Vittinghoff,et al.  Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  E. Larson,et al.  Proton pump inhibitor use and the risk of fractures among an older adult cohort , 2018, Pharmacoepidemiology and drug safety.

[30]  J. S. San Martin,et al.  Burosumab Therapy in Children with X‐Linked Hypophosphatemia , 2018, The New England journal of medicine.

[31]  Jun Pu,et al.  Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Front. Pharmacol..

[32]  J. Cauley,et al.  Treatment‐Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti‐Resorptive Drugs: A Meta‐Regression , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  B. Liu,et al.  Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies , 2018, Osteoporosis International.

[34]  V. Levin,et al.  Estrogen therapy for osteoporosis in the modern era , 2018, Osteoporosis International.

[35]  I. Chiodini,et al.  Protective Effect of Denosumab on Bone in Older Women with Primary Hyperparathyroidism , 2018, Journal of the American Geriatrics Society.

[36]  E. Siris,et al.  Hip fracture trends in the United States, 2002 to 2015 , 2018, Osteoporosis International.

[37]  L. Fang,et al.  Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis , 2018, Osteoporosis International.

[38]  S. Haneuse,et al.  Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three‐group matching weights , 2018, Pharmacoepidemiology and drug safety.

[39]  Jacques P. Brown,et al.  Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  J. Bilezikian,et al.  Hyperparathyroidism , 2018, The Lancet.

[41]  Sanjeev Arora,et al.  Leveraging Scarce Resources With Bone Health TeleECHO to Improve the Care of Osteoporosis , 2017, Journal of the Endocrine Society.

[42]  D. Hans,et al.  Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial. , 2017, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[43]  M. Popovic,et al.  Evaluating the efficacy of functional electrical stimulation therapy assisted walking after chronic motor incomplete spinal cord injury: effects on bone biomarkers and bone strength , 2017, The journal of spinal cord medicine.

[44]  J. Manson,et al.  Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials , 2017, JAMA.

[45]  A. Grauer,et al.  Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis , 2017, The New England journal of medicine.

[46]  N. Watts.  Adverse bone effects of medications used to treat non-skeletal disorders , 2017, Osteoporosis International.

[47]  D. Nickerson,et al.  MED resulting from recessively inherited mutations in the gene encoding calcium‐activated nucleotidase CANT1 , 2017, American journal of medical genetics. Part A.

[48]  F. Glorieux,et al.  BPS804 Anti‐Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  A. Qaseem,et al.  Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. , 2017, Annals of internal medicine.

[50]  E. Yu,et al.  Fracture Risk After Bariatric Surgery: Roux‐en‐Y Gastric Bypass Versus Adjustable Gastric Banding , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  J. Reginster,et al.  The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation , 2017, Oncotarget.

[52]  E. Mornet.  Genetics of hypophosphatasia. , 2017, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[53]  L. Brody,et al.  Copy-number variants and candidate gene mutations in isolated split hand/foot malformation , 2017, Journal of Human Genetics.

[54]  N. Scopinaro,et al.  Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014 , 2017, Obesity Surgery.

[55]  J. Shepherd,et al.  Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases. , 2017, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[56]  C. Cooper,et al.  Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG , 2017, Journal of bone oncology.

[57]  P. Giannoudis,et al.  Atypical femoral fractures related to bisphosphonate treatment: ISSUES AND CONTROVERSIES RELATED TO THEIR SURGICAL MANAGEMENT , 2017, The bone & joint journal.

[58]  V. Gudnason,et al.  Imminent risk of fracture after fracture , 2017, Osteoporosis International.

[59]  G. Forrest,et al.  Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options , 2017, Osteoporosis International.

[60]  M. Bredella,et al.  Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue. , 2017, Bone.

[61]  F. Grodstein,et al.  Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project , 2017, Journal of internal medicine.

[62]  D. Kiel,et al.  Goal‐Directed Treatment for Osteoporosis: A Progress Report From the ASBMR‐NOF Working Group on Goal‐Directed Treatment for Osteoporosis , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  J. Manson,et al.  No Increase in Fractures After Stopping Hormone Therapy: Results From the Women’s Health Initiative , 2016, The Journal of clinical endocrinology and metabolism.

[64]  A. Grauer,et al.  Romosozumab Treatment in Postmenopausal Women with Osteoporosis. , 2016, The New England journal of medicine.

[65]  C. Christiansen,et al.  Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial. , 2016, JAMA.

[66]  S. Khosla,et al.  A Crisis in the Treatment of Osteoporosis , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  P. Gamache,et al.  Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study , 2016, British Medical Journal.

[68]  R. Neer,et al.  Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial. , 2016, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[69]  M. Bouxsein,et al.  Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study). , 2016, The Journal of clinical endocrinology and metabolism.

[70]  P. Pietschmann,et al.  The Impact of Vitamin D, Calcium, Protein Supplementation, and Physical Exercise on Bone Metabolism After Bariatric Surgery: The BABS Study , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[71]  N. Panay,et al.  2016 IMS Recommendations on women’s midlife health and menopause hormone therapy , 2016, Climacteric : the journal of the International Menopause Society.

[72]  M. Bouxsein,et al.  Type 2 diabetes and the skeleton: new insights into sweet bones. , 2016, The lancet. Diabetes & endocrinology.

[73]  Hang Lee,et al.  Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial , 2015, The Lancet.

[74]  J. Carter,et al.  Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  E. Shane,et al.  Update on osteoporosis from the 2014 Santa Fe Bone symposium , 2015, Endocrine research.

[76]  N. Ács,et al.  Treatment of Endometriosis‐Associated Pain with Elagolix, an Oral GnRH Antagonist , 2017, The New England journal of medicine.

[77]  P. Pietschmann,et al.  Sclerostin levels and changes in bone metabolism after bariatric surgery. , 2015, The Journal of clinical endocrinology and metabolism.

[78]  M. Bouxsein,et al.  Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA‐HRpQCT Study , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  D. Solomon,et al.  Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011 , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[80]  E. Yu.  Bone Metabolism After Bariatric Surgery , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[81]  E. Losina,et al.  The Potential Economic Benefits of Improved Postfracture Care: A Cost‐Effectiveness Analysis of a Fracture Liaison Service in the US Health‐Care System , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[82]  D. Kiel,et al.  Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium. , 2014, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[83]  A. Kaunitz.  Extended duration use of menopausal hormone therapy. , 2014, Menopause.

[84]  M. Peacock,et al.  Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. , 2014, The Journal of clinical investigation.

[85]  Graham A Colditz,et al.  The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. , 2014, JAMA surgery.

[86]  Lewis H Kuller,et al.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. , 2013, JAMA.

[87]  E. Canalis.  Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches , 2013, Nature Reviews Endocrinology.

[88]  M. Bouxsein,et al.  Osteoporosis update from the 2012 Santa Fe Bone Symposium. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[89]  C. Cooper,et al.  Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle , 2013, Osteoporosis International.

[90]  Daniel B. Jones,et al.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery* , 2013, Obesity.

[91]  E. Nelson,et al.  The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis. , 2013, Bone.

[92]  Daniel B. Jones,et al.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. , 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[93]  P. Byers,et al.  Osteogenesis imperfecta , 2012, Nature Reviews Disease Primers.

[94]  S. Silverman,et al.  Incidence of atypical nontraumatic diaphyseal fractures of the femur , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[95]  Marcea Whitaker,et al.  Bisphosphonates for osteoporosis--where do we go from here? , 2012, The New England journal of medicine.

[96]  Nick Bishop,et al.  Enzyme-replacement therapy in life-threatening hypophosphatasia. , 2012, The New England journal of medicine.

[97]  G. Greendale,et al.  Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN) , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[98]  W. Wilcox,et al.  Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias , 2012, Human mutation.

[99]  Thomas D Brown,et al.  Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[100]  I. Holm,et al.  A clinician's guide to X‐linked hypophosphatemia , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[101]  Sanjeev Arora,et al.  Outcomes of treatment for hepatitis C virus infection by primary care providers. , 2011, The New England journal of medicine.

[102]  Sheila Unger,et al.  Nosology and Classification of Genetic Skeletal Disorders: 2010 Revision , 2011, American journal of medical genetics. Part A.

[103]  J. Eisman,et al.  Osteoporosis medication and reduced mortality risk in elderly women and men. , 2011, The Journal of clinical endocrinology and metabolism.

[104]  E. Salpeter,et al.  Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. , 2009, The American journal of medicine.

[105]  C. Benhamou,et al.  Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.

[106]  B. Wong,et al.  The Relationship Between Fractures and DXA Measures of BMD in the Distal Femur of Children and Adolescents With Cerebral Palsy or Muscular Dystrophy , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[107]  R. Eastell,et al.  2008 Santa Fe Bone Symposium: update on osteoporosis. , 2009, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[108]  Qing Chen,et al.  Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[109]  K. Saag,et al.  Quality health care gaps in osteoporosis: How can patients, providers, and the health system do a better job? , 2009, Current osteoporosis reports.

[110]  S. Mundlos,et al.  Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1 , 2009, Human mutation.

[111]  J. Eisman,et al.  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. , 2009, JAMA.

[112]  C. Furberg,et al.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis , 2009, Canadian Medical Association Journal.

[113]  C. Cooper,et al.  Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. , 2008, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[114]  Ego Seeman,et al.  Bone quality: the material and structural basis of bone strength , 2008, Journal of Bone and Mineral Metabolism.

[115]  S. Silverman,et al.  Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[116]  J. Hecht,et al.  Achondroplasia , 2007, The Lancet.

[117]  E. Szalay,et al.  Bone Mineral Density Correlation With Fractures in Nonambulatory Pediatric Patients , 2007, Journal of pediatric orthopedics.

[118]  J. Manson,et al.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. , 2007, JAMA.

[119]  E. Lewiecki.  Proceedings of the Santa Fe Bone Symposium 2006 , 2006, Women's health.

[120]  A. LaCroix,et al.  Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[121]  P. Miller,et al.  Denosumab in Postmenopausal Women with Low Bone Mineral Density , 2007 .

[122]  M. Suter,et al.  Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up , 2005, International Journal of Obesity.

[123]  P. Vestergaard.  Epilepsy, osteoporosis and fracture risk – a meta‐analysis , 2005, Acta neurologica Scandinavica.

[124]  D. Black,et al.  Clinical Practice. Postmenopausal Osteoporosis. , 2005, The New England journal of medicine.

[125]  L. Battistella,et al.  Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study , 2005, Spinal Cord.

[126]  P. Vestergaard,et al.  Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark , 2005, Osteoporosis International.

[127]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[128]  A. LaCroix,et al.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. , 2003, JAMA.

[129]  F. Miller,et al.  Fractures in Patients With Cerebral Palsy , 2003, Journal of pediatric orthopedics.

[130]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[131]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[132]  Susan R. Johnson,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.

[133]  R. Turner,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1–34) on Bone Histomorphometry and Serum Chemistry in Rats* , 2022 .

[134]  S. Nightingale.  Alendronate Approved for Bone Disorders , 1995 .

[135]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[136]  L. Melton,et al.  The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.

[137]  C. Slemenda,et al.  Age and bone mass as predictors of fracture in a prospective study. , 1988, The Journal of clinical investigation.

[138]  P. Kostenuik,et al.  Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[139]  C. Gordon,et al.  Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis. , 2018, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[140]  R. Hamdy.  Osteoporosis: Heading Towards the Perfect Storm. , 2018, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[141]  J. Pinkerton.  The 2017 hormone therapy position statement of The North American Menopause Society. , 2017, Menopause.

[142]  Sanjeev Arora,et al.  Telementoring: a novel approach to reducing the osteoporosis treatment gap , 2016, Osteoporosis International.

[143]  R. Baron,et al.  Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone Disease. , 2016, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[144]  T. Gardella,et al.  Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling. , 2016, Endocrinology.

[145]  L. Spangler,et al.  Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. , 2015, Mayo Clinic proceedings.

[146]  Deborah Krakow,et al.  Skeletal dysplasias. , 2015, Clinics in perinatology.

[147]  R. Ersoy,et al.  Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy , 2014, Osteoporosis International.

[148]  L. Giangregorio,et al.  Exploring the determinants of fracture risk among individuals with spinal cord injury , 2013, Osteoporosis International.

[149]  JoAnn E Manson,et al.  Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. , 2013, Obstetrics and gynecology.

[150]  E. McCloskey,et al.  Proceedings of the 2011 Santa Fe Bone symposium. , 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[151]  R. Marcus,et al.  Osteoporosis update from the 2010 santa fe bone symposium. , 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[152]  R. Recker,et al.  2009 Santa Fe Bone symposium. , 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[153]  B. Burnand,et al.  The RAND/UCLA Appropriateness Method User's Manual , 2001 .